@article{a9f5e1077bb946a69e83db4ffadb6964,
title = "Commentary: GSK-3 Inhibition as a Therapeutic Approach Against SARs CoV2: Dual Benefit of Inhibiting Viral Replication While Potentiating the Immune Response",
keywords = "9-ING-41, COVID, COVID-19, GSK-3 inhibitor, GSK-3b inhibitor, SARS-CoV21, glycogen synthase kinase-3 (GSK-3) inhibitor, glycogen synthase kinase-3 (GSK3)",
author = "{De Souza}, Andre and Tavora, {Fabio A.} and Devalingam Mahalingam and Munster, {Pamela N.} and Safran, {Howard P.} and El-Deiry, {Wafik S.} and Carneiro, {Benedito A.}",
year = "2020",
month = oct,
day = "19",
doi = "10.3389/fimmu.2020.595289",
language = "English (US)",
volume = "11",
journal = "Frontiers in Immunology",
issn = "1664-3224",
publisher = "Frontiers Media S. A.",
}